<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMM</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1107-3756</issn>
<issn pub-type="epub">1791-244X</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijmm.2015.2394</article-id>
<article-id pub-id-type="publisher-id">ijmm-37-01-0074</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>The activation of p38 MAPK limits the abnormal proliferation of vascular smooth muscle cells induced by high sodium concentrations</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>WU</surname><given-names>YAN</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref><xref rid="fn1-ijmm-37-01-0074" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>ZHOU</surname><given-names>JUAN</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref><xref rid="af2-ijmm-37-01-0074" ref-type="aff">2</xref><xref rid="fn1-ijmm-37-01-0074" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author">
<name><surname>WANG</surname><given-names>HUAN</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>WU</surname><given-names>YUE</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>GAO</surname><given-names>QIYUE</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>WANG</surname><given-names>LIJUN</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref><xref rid="af2-ijmm-37-01-0074" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>ZHAO</surname><given-names>QIANG</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>LIU</surname><given-names>PEINING</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>GAO</surname><given-names>SHANSHAN</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>WEN</surname><given-names>WEN</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>ZHANG</surname><given-names>WEIPING</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>LIU</surname><given-names>YAN</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>YUAN</surname><given-names>ZUYI</given-names></name><xref rid="af1-ijmm-37-01-0074" ref-type="aff">1</xref><xref rid="af2-ijmm-37-01-0074" ref-type="aff">2</xref><xref rid="af3-ijmm-37-01-0074" ref-type="aff">3</xref><xref ref-type="corresp" rid="c1-ijmm-37-01-0074"/></contrib></contrib-group>
<aff id="af1-ijmm-37-01-0074">
<label>1</label>Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi 710061, P.R. China</aff>
<aff id="af2-ijmm-37-01-0074">
<label>2</label>Shaanxi Key Laboratory of Molecular Cardiology, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China</aff>
<aff id="af3-ijmm-37-01-0074">
<label>3</label>Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China</aff>
<author-notes>
<corresp id="c1-ijmm-37-01-0074">Correspondence to: Professor Zuyi Yuan, Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi 710061, P.R. China E-mail: <email>zuyiyuan@mail.xjtu.edu.cn</email></corresp><fn id="fn1-ijmm-37-01-0074">
<label>&#x0002A;</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="ppub">
<month>01</month>
<year>2016</year></pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>10</month>
<year>2015</year></pub-date>
<volume>37</volume>
<issue>1</issue>
<fpage>74</fpage>
<lpage>82</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>06</month>
<year>2015</year></date>
<date date-type="accepted">
<day>23</day>
<month>10</month>
<year>2015</year></date></history>
<permissions>
<copyright-statement>Copyright: &#x000A9; Wu et al.</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions>
<abstract>
<p>The aim of the present study was to ascertain whether high sodium levels can directly promote the proliferation of vascular smooth muscle cells (VSMCs) and to elucidate the underlying mechanisms. Additional sodium chloride (NaCl) was added to the routine culture medium. Cell proliferation was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and 5-ethynyl-2&#x02032;-deoxyuridine (EdU) incorporation assay. The mRNA expression level of proliferating cell nuclear antigen (PCNA) was measured by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The protein expression levels of PCNA and phosphorylated c-Jun amino N-terminal kinase (p-JNK), phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2) and phosphorylated p38 mitogen-activated protein kinase (p-p38 MAPK) were measured by western blot analysis. Cell proliferation assay revealed that Na<sup>+</sup> rather than Cl<sup>&#x02212;</sup> or osmotic pressure promoted the proliferation of the VSMCs. The high sodium level upregulated the expression of PCNA and the phosphorylation levels of JNK, ERK1/2 and p38 MAPK. The inhibition of JNK and ERK1/2 decreased PCNA expression. Of note, the inhibition of p38 MAPK using the inhibitor, SB203580, increased PCNA expression. However, when p38 MAPK was activated by anisomycin, PCNA expression was decreased. On the whole, our findings demonstrate that a relatively high sodium level per se directly promotes the proliferation of VSMCs through the JNK/ERK1/2/PCNA pathway. At the same time, this induction of the proliferation of VSMCs due to high sodium levels can be maintained at a low level via the activation of p38 MAPK.</p></abstract>
<kwd-group>
<kwd>c-Jun N-terminal kinase</kwd>
<kwd>vascular smooth muscle cells</kwd>
<kwd>extracellular signal-regulated kinase 1/2</kwd>
<kwd>sodium</kwd>
<kwd>proliferation</kwd>
<kwd>p38 mitogen-activated protein kinase</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>As the principal cation in extracellular fluid, sodium (Na<sup>+</sup>) is an essential nutrient for the maintenance of normal cell function. However, a high-sodium diet (HSD) has been widely be implicated in the development of hypertension (<xref rid="b1-ijmm-37-01-0074" ref-type="bibr">1</xref>&#x02013;<xref rid="b3-ijmm-37-01-0074" ref-type="bibr">3</xref>) and cardiovascular diseases, particularly fatal coronary heart diseases (<xref rid="b1-ijmm-37-01-0074" ref-type="bibr">1</xref>,<xref rid="b4-ijmm-37-01-0074" ref-type="bibr">4</xref>) and stroke (<xref rid="b1-ijmm-37-01-0074" ref-type="bibr">1</xref>).</p>
<p>Under physiological conditions, cells, such as inner medullary collecting duct (IMCD) cells of the collecting duct and vascular smooth muscle cells (VSMCs) of renal capillaries in the renal medulla, are normally exposed to variably high concentrations of urea and sodium chloride (NaCl), as a consequence of the urine concentrating mechanism (<xref rid="b5-ijmm-37-01-0074" ref-type="bibr">5</xref>). Under antidiuretic conditions, NaCl and urea are the most prevalent solutes in the medullary interstitium (<xref rid="b6-ijmm-37-01-0074" ref-type="bibr">6</xref>). <italic>In vitro</italic> studies have reported that when IMCD3 cells are exposed to culture medium to which extreme high concentrations of NaCl are added, this may lead to DNA damage (212.5 mM NaCl added) (<xref rid="b7-ijmm-37-01-0074" ref-type="bibr">7</xref>), oxidative stress (300 mM NaCl added) (<xref rid="b8-ijmm-37-01-0074" ref-type="bibr">8</xref>) and cell cycle arrest (100 mM NaCl added) (<xref rid="b9-ijmm-37-01-0074" ref-type="bibr">9</xref>). Therefore, the mechanisms responsible for the adaptation of cells such as IMCD3 and VSMCs to various concentrations of Na<sup>+</sup> remain poorly understood and thus warrant further investigations.</p>
<p>Apart from the renal medulla, the interstitium containing large amounts of glycosaminoglycans is considered to be a separately regulated space for Na<sup>+</sup> homeostasis (<xref rid="b10-ijmm-37-01-0074" ref-type="bibr">10</xref>,<xref rid="b11-ijmm-37-01-0074" ref-type="bibr">11</xref>). Long-term balance studies on humans have confirmed that considerable amounts of Na<sup>+</sup> accumulate in the interstitium due to excessive NaCl consumption (<xref rid="b12-ijmm-37-01-0074" ref-type="bibr">12</xref>&#x02013;<xref rid="b14-ijmm-37-01-0074" ref-type="bibr">14</xref>). The skin Na<sup>+</sup> concentration due to HSD can be as high as 180 to 190 mM in rats (<xref rid="b15-ijmm-37-01-0074" ref-type="bibr">15</xref>). The study by Machnik <italic>et al</italic> further demonstrated that the interstitial accumulation of Na<sup>+</sup> in skin results in hyperplasia of the lymph capillary network (<xref rid="b10-ijmm-37-01-0074" ref-type="bibr">10</xref>). Therefore, apart from physiological conditions in the renal medulla, it is necessary to further address whether HSD can lead to excess Na<sup>+</sup> accumulation in different tissues and whether this Na<sup>+</sup> retention may be associated with any adverse effects.</p>
<p>It should be noted that salt restriction further improves blood pressure control in patients treated with a combination of an angiotensin-converting enzyme (ACE) inhibitor and a diuretic (<xref rid="b16-ijmm-37-01-0074" ref-type="bibr">16</xref>). Matsushita <italic>et al</italic> also found that the combination of HSD with bilateral oophorectomy significantly increased the body Na<sup>+</sup>/water ratio, and increased cerebral aneurysm formation irrespective of hypertension (<xref rid="b17-ijmm-37-01-0074" ref-type="bibr">17</xref>). The abnormal proliferation of VSMCs is considered responsible for the physiological and pathophysiological changes taking place in the vascular wall (<xref rid="b18-ijmm-37-01-0074" ref-type="bibr">18</xref>,<xref rid="b19-ijmm-37-01-0074" ref-type="bibr">19</xref>). In this study, we aimed to assess whether Na<sup>+</sup> per se directly affects the proliferation of VSMCs at relatively higher concentrations and to elucidate the underlying mechanisms. This may firstly shed light on the mechanisms responsible for the adaptation of VSMCs to high concentrations of Na<sup>+</sup>, and secondly, it may reveal the possible direct pathogenic effect of the excessive consumption of Na<sup>+</sup>, which is independent of pressure, the renin-angiotensin-aldosterone system (RAAS) (<xref rid="b20-ijmm-37-01-0074" ref-type="bibr">20</xref>,<xref rid="b21-ijmm-37-01-0074" ref-type="bibr">21</xref>) and endothelial function (<xref rid="b22-ijmm-37-01-0074" ref-type="bibr">22</xref>).</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<sec>
<title>Reagents, kits and antibodies</title>
<p>Dulbecco's modified Eagle's medium (DMEM)/high glucose and phenol red-free DMEM were purchased from HyClone (Logan, UT, USA). Charcoal stripped fetal bovine serum (FBS) was obtained from Gibco-BRL (Grand Island, NY, USA). Rabbit monoclonal antibodies against proliferating cell nuclear antigen (PCNA; 1:1,000; #13110), phosphorylated c-Jun amino N-terminal kinases (p-JNK; 1:1,000; #4668) and phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2; 1:2,000; #4370) were provided by Cell Signaling Technology (Beverly, MA, USA). Rabbit polyclonal antibody against phosphorylated p38 mitogen-activated protein kinase (p-p38 MAPK) was supplied by Signalway Antibody LLC (College Park, MD, USA). Rabbit monoclonal antibody against &#x003B2;-actin (1:10,000; JC-PA-&#x003B2;A1) and horseradish peroxidase-conjugated goat-anti-rabbit antibody (1:4,000; JC-PC012-1h) were purchased from Geneshare (Xi'an, Shannxi, China). NaCl, choline chloride, sorbital, mouse monoclonal anti-actin, &#x003B1;-smooth muscle-FITC antibody (anti-&#x003B1;-SM-actin antibody; F3777) and DAPI were obtained from Sigma-Aldrich (St. Louis, MO, USA). The Cell-Light&#x02122; 5-ethynyl-2&#x02032;-deoxyuridine (EdU) imaging detecting kit was purchased from RiboBio (Guangzhou, China). SP600125 (a JNK inhibitor) was provided by Cell Signaling Technology. PD98059 (an ERK1/2 inhibitor), SB203580 (a p38 MAPK inhibitor) and anisomycin (a p38 MAPK activator) were supplied from Santa Cruz Biotechnology (Dallas, TX, USA). In addition, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-razolium bromide (MTT) was purchased from Amresco (Solon, OH, USA).</p></sec>
<sec>
<title>Cell culture and treatment</title>
<p>Rat VSMCs were purchased from CHI Scientific, Inc. (Jiangsu, China) and cultured in DMEM supplemented with 10% FBS at 37&#x000B0;C under 5% CO<sub>2</sub>/95% air in a humidified incubator. Cells at passages 3 to 8 with a purity of &gt;95% (determined by immunofluorescence staining for &#x003B1;-SM-actin) were used in the experiments. In order to obtain quiescent VSMCs, the cells were incubated in serum-free medium for 24 h. Subsequently, standard DMEM supplemented with 5% FBS was used as the control culture medium, in which the Na<sup>+</sup> concentration was approximately 156 mM. High-sodium medium was prepared by the addition of NaCl (10, 20, 30, 40 and 50 mM,respectively; additional to the levels already present in the medium) to the control culture medium. Choline chloride and sorbital were used to examine the effects of chloridion (Cl<sup>&#x02212;</sup>) and osmotic pressure on the proliferation of the VSMCs. High-Cl<sup>&#x02212;</sup> medium was prepared by the addition of choline chloride (10, 20, 30, and 50 mM, respectively; additional to the levels already present in the medium) to the control culture medium. High-osmotic pressure medium was prepared by the addition of sorbital (20, 40, 60, 80 and 100 mM, respectively; additional to the levels already present in the medium) to the control culture medium. For MTT assay, the VSMCs were treated for 12, 24 or 48 h. For EdU incorporation assay, the VSMCs were treated for 24 h. PCNA expression at the mRNA level was detected following treatment for 3, 6, 9 and 12 h. PCNA expression at the protein level was detected following treatment for 6, 15, or 24 h. Phosphorylation levels were detected after 15, 30, 60, 90 and 120 min of intervention. To examine the effects of 3 MAPK members on the proliferation of VSMCs induced by additional NaCl, the cells were pre-treated wtih SP600125 (a JNK inhibitor), PD98059 (an ERK1/2 inhibitor), SB203580 (a p38 MAPK inhibitor) and anisomycin (a p38 MAPK activator) for 30 min.</p></sec>
<sec>
<title>Immunofluorescence staining</title>
<p>The VSMCs were cultured on sterile glass cover slips in 12-well plates. Following fixation with 4% paraformaldehyde, the VSMCs were permeabilized by 0.1% Triton X-100 for 30 min at room temperature and blocked with goat serum for 1 h at 37&#x000B0;C. The cells then covered with anti-&#x003B1;-SM-actin antibody were incubated at 4&#x000B0;C in a dark humidified chamber overnight. The samples were counter-stained with DAPI at room temperature for 10 min. The images were captured using NIS-Elements imaging software (Nikon, Tokyo, Japan).</p></sec>
<sec>
<title>MTT assay</title>
<p>Cell proliferation was firstly investigated by MTT assay according to published literature (<xref rid="b23-ijmm-37-01-0074" ref-type="bibr">23</xref>). Briefly, the VSMCs were treated with additional NaCl (10&#x02013;50 mM), choline chloride (10&#x02013;50 mM) or sorbital (20&#x02013;100 mM) in DMEM supplemented with 5% FBS for 12, 24 or 48 h. The cells were then incubated with MTT solution (0.1 mg/ml) for 4 h. The formed formazan crystals were dissolved in 150 <italic>&#x003BC;</italic>l/well dimethyl sulfoxide (DMSO). The absorbance was recorded at a wavelength of 490 nm using a microplate reader (Bio-Rad, Hercules, CA, USA). All experiments were performed at least 3 times. The relative proliferation of the cells was calculated as the absorbance of treated cells/control cells &#x000D7;100%.</p></sec>
<sec>
<title>EdU incorporation assay</title>
<p>Following synchronization with serum-free medium for 24 h, the cells were treated with or without additional NaCl (30 mM) in DMEM supplemented with 5% FBS for 24 h. The EdU incorporation assay was performed according to the manufacturer's instructions (RiboBio). In brief, the VSMCs were incubated with 50 <italic>&#x003BC;</italic>M EdU for 2 h. Following fixation with 4% paraformaldehyde and permeabilization in 1.0% Triton X-100, the cells underwent EdU staining. The cell nuclei were counterstained with Hoechst 33342. EdU-positive nuclei were determined under a fluorescence microscope (Olympus BX51; Olympus, Tokyo, Japan). The cell proliferation rate was calculated as the proportion of nucleated cells incorporating EdU in 5 high-power fields per well.</p></sec>
<sec>
<title>RNA extraction and reverse transcription-quantitative polymerase chain reaction (RT-qPCR)</title>
<p>Quantification was carried out as previously described (<xref rid="b24-ijmm-37-01-0074" ref-type="bibr">24</xref>). Briefly, total RNA was extracted from the cells using TRIzol reagent and reverse transcribed using the cDNA synthesis kit (Fermentas, Burlington, CA, USA). Quantitative (real-time) PCR (qPCR) was performed using SYBR<sup>&#x000AE;</sup> select Master Mix on an iQ5 Multicolor Real-Time PCR Detection system (Bio-Rad). The primer sequences used for PCNA were as follows: sense, 5&#x02032;-ACCTCACCAGC ATGTCCAA-3&#x02032; and antisense, 5&#x02032;-CATAGTCTGAAACTTTC TCTTGATTTG-3&#x02032;. Beta-glucuronidase (GUSB) was used as a housekeeping gene and the primer sequences were: sense, 5&#x02032;-CTCTGGTGGCCTTACCTGAT-3&#x02032; and antisense, 5&#x02032;-CAGA CTCAGGTGTTGTCA TCG-3&#x02032;. The relative expression level of the target gene was then determined using a comparative method (2<sup>&#x02212;&#x00394;&#x00394;CT</sup>).</p></sec>
<sec>
<title>Western blot analysis</title>
<p>Western blot analysis was performed as previously described (<xref rid="b24-ijmm-37-01-0074" ref-type="bibr">24</xref>). Briefly, the VSMCs were lysed in RIPA buffer supplemented with protease and phosphatase inhibitors. The protein content was determined using a BCA protein assay kit (Pierce, Rockford, IL, USA). Equivalent amounts of protein were subjected to 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for electrophoresis and then transferred onto PVDF membranes (Bio-Rad). The blots were incubated with primary antibodies against PCNA, p-JNK, p-ERK1/2, p-p38 MAPK and &#x003B2;-actin, and then with horseradish peroxidase-conjugated goat-anti-rabbit antibody. The protein signals were detected using chemiluminescence. All densitometric data for the target genes were corrected with &#x003B2;-actin as a loading control.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>Data are expressed as the means &#x000B1; standard deviation (SD). Comparisons among 3 or more groups were analyzed by one-way analysis of variance (ANOVA), whereas the Student's t-test was used for comparisons between 2 groups. A value of P&lt;0.05 was considered to indicate a statistically significant difference. Statistical analysis was performed using SPSS 16.0 software (SPSS, Inc., Chicago, IL, USA).</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>High sodium levels rather than high Cl<sup>&#x02212;</sup> levels or osmotic pressure promote the proliferation of VSMCs</title>
<p>In the present study, we used &#x003B1;-SM-actin as a marker of contractile VSMCs to identify the phenotype and purity of the commercially available VSMCs (<xref rid="b25-ijmm-37-01-0074" ref-type="bibr">25</xref>). The cultured VSMCs exhibited a spindle-like shape. Immunofluorescence staining revealed an abundance of green myonemes in the cytoplasm. The purity of the obtained cells was &gt;95% (data not shown).</p>
<p>Additional NaCl was added to the basal medium in order to verify whether Na<sup>+</sup> directly promotes the proliferation of VSMCs at higher concentrations. First, MTT assay was used to evaluate cell proliferation. Following incubation for 24 h, the addition of 20&#x02013;40 mM NaCl to the cell medium markedly promoted the proliferation of the VSMCs compared with the untreated control group (<xref rid="f1-ijmm-37-01-0074" ref-type="fig">Fig. 1A</xref>). Furthermore, this induction of cell proliferation by the high sodium levels was the most significant when 30 mM NaCl were added. To further clarify whether the proliferative effects of NaCl on VSMCs are due to Na<sup>+</sup> itself, choline chloride and sorbital were also employed in the present study. Choline chloride at various concentrations, which was used as Cl<sup>&#x02212;</sup> intervention, did not increase the proliferation of the VSMCs (<xref rid="f1-ijmm-37-01-0074" ref-type="fig">Fig. 1B</xref>). Sorbital, which was used as osmotic intervention, exhibited no significant effect on the proliferation of the VSMCs (<xref rid="f1-ijmm-37-01-0074" ref-type="fig">Fig. 1C</xref>) at low concentrations (20 and 40 mM). Indeed, sorbital inhibited the proliferation of the VSMCs when used at a concentration of &gt;60 mM. As shown in <xref rid="f1-ijmm-37-01-0074" ref-type="fig">Fig. 1D</xref>, the addition of NaCl (30 mM; additional to the levels already in medium) to the cell medium promoted the proliferation of the VSMCs following incubation for 24 and 48 h, but not for 12 h. These results indicated that Na<sup>+</sup> at relatively high concentrations per se, rather than Cl<sup>&#x02212;</sup> or osmotic pressure promoted the proliferation of VSMCs.</p>
<p>EdU, a thymidine analogue, is incorporated into cellular DNA during cell proliferation (<xref rid="b26-ijmm-37-01-0074" ref-type="bibr">26</xref>). Thus, in this study, we used the EdU incorporation assay to further confirm the effects of high sodium levels on the proliferation of VSMCs. In accordance with the results of MTT assay, EdU incorporation assay revealed that addition of NaCl (30 mM; additional to the levels already in medium) to the cell culture medium for 24 h increased the percentage of EdU-positive nuclei compared with the control group (<xref rid="f2-ijmm-37-01-0074" ref-type="fig">Fig. 2</xref>), thus indicating an increase in DNA synthesis in the ultured VSMCs which was induced by NaCl.</p></sec>
<sec>
<title>High sodium level increases PCNA expression at both the mRNA and protein levels</title>
<p>PCNA, the eukaryotic DNA sliding clamp, confers high processivity to replicative DNA polymerase, which is recognized as a marker of cell proliferation (<xref rid="b27-ijmm-37-01-0074" ref-type="bibr">27</xref>,<xref rid="b28-ijmm-37-01-0074" ref-type="bibr">28</xref>). We thus measured the mRNA and protein expression levels of PCNA in the cells cultured in medium with the addition of high level of sodium. As shown in <xref rid="f3-ijmm-37-01-0074" ref-type="fig">Fig. 3A</xref>, the mRNA expression of PCNA was significantly increased following the addition of 30 mM Na<sup>+</sup> to the cell culture medium (additional to the levels already in medium) for 6 and 9 h. In addition, the protein expression of PCNA was transiently, but markedly increased following the addition of Na<sup>+</sup> to the medium for 15 h (<xref rid="f3-ijmm-37-01-0074" ref-type="fig">Fig. 3B</xref>).</p></sec>
<sec>
<title>High sodium level increases the phosphorylation levels of JNK, ERK1/2 and p38 MAPK</title>
<p>JNK, ERK1/2 and p38 MAPK are the members of MAPK family, and they play important roles in cell proliferation (<xref rid="b29-ijmm-37-01-0074" ref-type="bibr">29</xref>,<xref rid="b30-ijmm-37-01-0074" ref-type="bibr">30</xref>). Thus, in order to elucidate the underlying mechanisms responsible for the proliferative effects of additional Na<sup>+</sup> on VSMCs, we measured the phosphorylation levels of JNK, ERK1/2 and p38 MAPK by western blot analysis. As shown in <xref rid="f4-ijmm-37-01-0074" ref-type="fig">Fig. 4</xref>, the expression levels of p-JNK (<xref rid="f4-ijmm-37-01-0074" ref-type="fig">Fig. 4A and B</xref>), p-ERK1/2 (<xref rid="f4-ijmm-37-01-0074" ref-type="fig">Fig. 4C and D</xref>) and p-p38 MAPK (<xref rid="f4-ijmm-37-01-0074" ref-type="fig">Fig. 4E and F</xref>) were significantly increased following the addition of 30 mM Na<sup>+</sup> to the cell culture medium (additional to the levels already in medium) for 30 min, and such an increase was maintained until 120 min post-treatment.</p></sec>
<sec>
<title>High sodium level increases PCNA expression at the protein level through the JNK/ERK1/2 pathway</title>
<p>To further investigate the exact roles of MAPK members in the high-sodium induced proliferation of VSMCs, specific inhibitors of JNK and ERK1/2 were used in this study. As shown in <xref rid="f5-ijmm-37-01-0074" ref-type="fig">Fig. 5</xref>, both SP600125, a JNK inhibitor (<xref rid="f5-ijmm-37-01-0074" ref-type="fig">Fig. 5A</xref>), and PD98059, an ERK1/2 inhibitor (<xref rid="f5-ijmm-37-01-0074" ref-type="fig">Fig. 5B</xref>), almost completely inhibited PCNA expression induced by the addition of Na<sup>+</sup> (30 mM; additional to the levels already in medium). The JNK inhibitor, SP600125, also decreased the expression of p-ERK1/2 which was induced by the addition of Na<sup>+</sup> (30 mM; additional to the levels already in medium) (<xref rid="f5-ijmm-37-01-0074" ref-type="fig">Fig. 5C</xref>). However, the ERK1/2 inhibitor, PD98059, did not significantly affect the phosphorylation level of JNK (<xref rid="f5-ijmm-37-01-0074" ref-type="fig">Fig. 5D</xref>). These results indicated that high sodium levels induced the expression of PCNA through JNK/ERK1/2 pathway, and that JNK was located upstream of ERK1/2.</p></sec>
<sec>
<title>High sodium level simultaneously inhibits PCNA expression through p38 MAPK</title>
<p>In the present study, we also used SB203580 (a p38 MAPK inhibitor) in order to examine the role of p38 MAPK in the high-sodium induced proliferation of VSMCs. Surprisingly, SB203580 markedly increased PCNA expression at the protein level (<xref rid="f6-ijmm-37-01-0074" ref-type="fig">Fig. 6A</xref>). Conversely, anisomycin, the activator of p38 MAPK, inhibited PCNA expression (<xref rid="f6-ijmm-37-01-0074" ref-type="fig">Fig. 6B</xref>). These results suggested that activated p38 MAPK played an opposite role to JNK and ERK1/2 in the high-sodium induced proliferation of VSMCs.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>As the major risk factor for cardiovascular diseases (<xref rid="b1-ijmm-37-01-0074" ref-type="bibr">1</xref>&#x02013;<xref rid="b4-ijmm-37-01-0074" ref-type="bibr">4</xref>,<xref rid="b31-ijmm-37-01-0074" ref-type="bibr">31</xref>), increasing attention has been paid to the physiological and pathophysiological effects of excess Na<sup>+</sup> consumption. The present study demonstrated two major findings: i) Additional Na<sup>+</sup> per se increased the proliferation of VSMCs weakly (10%), but directly at relatively higher concentrations; ii) the addition of Na<sup>+</sup> activated the JNK/ERK1/2/PCNA pathway to promote the proliferation of VSMCs, and this abnormal proliferative effect was limited by simultaneously activated p38 MAPK.</p>
<p>In the present study, we mainly focused on the direct effects of additional NaCl on the proliferation of VSMCs to avoid the confounding impact from other factors, as shown in <italic>in vivo</italic> studies, such as RAAS (<xref rid="b20-ijmm-37-01-0074" ref-type="bibr">20</xref>,<xref rid="b21-ijmm-37-01-0074" ref-type="bibr">21</xref>), endothelial function (<xref rid="b22-ijmm-37-01-0074" ref-type="bibr">22</xref>) and ouabain (<xref rid="b32-ijmm-37-01-0074" ref-type="bibr">32</xref>). We demonstrated that additional Na<sup>+</sup> itself directly increased the proliferation of VSMCs at a concentration ranging from 20 to 40 mM (<xref rid="f1-ijmm-37-01-0074" ref-type="fig">Figs. 1</xref><xref rid="f2-ijmm-37-01-0074" ref-type="fig"/>&#x02013;<xref rid="f3-ijmm-37-01-0074" ref-type="fig">3</xref>). Since the basic culture medium of VSMCs is DMEM, in which the Na<sup>+</sup> concentration is approximately 156 mM, the final Na<sup>+</sup> concentrations thus ranged from 176 to 196 mM in the present study. This level of Na<sup>+</sup> concentration could appear both in the renal medulla under physiological conditions (<xref rid="b5-ijmm-37-01-0074" ref-type="bibr">5</xref>) and in the skin interstitium due to HSD (<xref rid="b10-ijmm-37-01-0074" ref-type="bibr">10</xref>). Although Na<sup>+</sup> increased the proliferation of VSMCs by only approximately 10% compared with the control group, and this effect is not as prominent as that of other factors, such as angiotensin II (<xref rid="b20-ijmm-37-01-0074" ref-type="bibr">20</xref>), its proliferative effects were still significant since i) the proliferation of the VSMCs was maintained at a low level when the cells were exposed to relatively higher concentrations of Na<sup>+</sup>. This interesting response of VSMCs to high concentrations of Na<sup>+</sup> may indicate a possible mechanism which plays a role in the adaptation of tissues exposed to fluctuant concentrations of Na<sup>+</sup> in the renal medulla; ii) aside from the increase in blood pressure, the activation of RAAS and endothelial dysfunction, the increase in the proliferation of the VSMCs by 10% induced by the interstitial Na<sup>+</sup> accumulation itself can still be considered as an important pathogenic factor for hypertension, cardiovascular disease and stroke; iii) as previously described by Singer <italic>et al</italic> (<xref rid="b16-ijmm-37-01-0074" ref-type="bibr">16</xref>), medication against RAAS and other possible treatments cannot solve all the health issues and sodium restriction itself is a simple, but significant prevention or even therapeutic approach.</p>
<p>As an extracellular stimuli, it has been proven that NaCl can affect MAPKs in several cell types, such as endothelial cells (<xref rid="b33-ijmm-37-01-0074" ref-type="bibr">33</xref>), monocytes (<xref rid="b34-ijmm-37-01-0074" ref-type="bibr">34</xref>) and HEK293 cells (<xref rid="b35-ijmm-37-01-0074" ref-type="bibr">35</xref>). For cell cycle progression, it is considered that the activation of JNK and ERK1/2 can accelerate cell proliferation (<xref rid="b36-ijmm-37-01-0074" ref-type="bibr">36</xref>,<xref rid="b37-ijmm-37-01-0074" ref-type="bibr">37</xref>), whereas p38 MAPK plays an opposite role (<xref rid="b38-ijmm-37-01-0074" ref-type="bibr">38</xref>&#x02013;<xref rid="b40-ijmm-37-01-0074" ref-type="bibr">40</xref>). In the present study, Na<sup>+</sup> increased the phosphorylation of JNK (<xref rid="f4-ijmm-37-01-0074" ref-type="fig">Fig. 4A</xref>) and ERK1/2 (<xref rid="f4-ijmm-37-01-0074" ref-type="fig">Fig. 4C</xref>) and increased PCNA expression (<xref rid="f5-ijmm-37-01-0074" ref-type="fig">Fig. 5</xref>), and these results were consistent with those of the above-mentioned studies. Moreover, p38 MAPK was phosphorylated (<xref rid="f4-ijmm-37-01-0074" ref-type="fig">Fig. 4E</xref>) at the same time, but played an opposite role (<xref rid="f6-ijmm-37-01-0074" ref-type="fig">Fig. 6</xref>). Since Na<sup>+</sup> is an essential nutrient for normal cell function, the findings of our study indicate that high sodium levels may simultaneously activate p38 MAPK, a negative regulatory mechanism, in order to limit abnormal proliferation, maintaining cell proliferation at a relatively low level.</p>
<p>There were several limitations to the present study as follows: i) in spite of the abundance of existing connective tissue, to the best of our knowledge, no studies to date have demonstrated the exact amount of Na<sup>+</sup> which is accumulated in the vascular wall. Therefore, it is necessary to develop a novel, but feasible method with which to determine the accumulation of Na<sup>+</sup> and measure its exact concentrations in the vascular walls due to HSD; ii) the detailed mechanisms and the cross- talk between JNK, ERK1/2 and p38 MAPK warrants further investigations.</p>
<p>In conclusion, the findings of this study demonstrated that additional Na<sup>+</sup> per se directly promoted the proliferation of VSMCs through the JNK/ERK1/2/PCNA pathway. At the same time, the proliferation of the VSMCs which was induced by additional Na<sup>+</sup> was maintained at a low level via the activation of p38 MAPK (<xref rid="f7-ijmm-37-01-0074" ref-type="fig">Fig. 7</xref>).</p></sec></body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This study was financially supported by the National Natural Science Fund (nos. 91339116 and 81102843) and the National Basic Research Program of China ('973 Project' no. 2012CB517804).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-ijmm-37-01-0074"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aburto</surname><given-names>NJ</given-names></name><name><surname>Ziolkovska</surname><given-names>A</given-names></name><name><surname>Hooper</surname><given-names>L</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Cappuccio</surname><given-names>FP</given-names></name><name><surname>Meerpohl</surname><given-names>JJ</given-names></name></person-group><article-title>Effect of lower sodium intake on health: Systematic review and meta-analyses</article-title><source>BMJ</source><volume>346</volume><fpage>f1326</fpage><year>2013</year><pub-id pub-id-type="doi">10.1136/bmj.f1326</pub-id><pub-id pub-id-type="pmid">23558163</pub-id></element-citation></ref>
<ref id="b2-ijmm-37-01-0074"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graudal</surname><given-names>NA</given-names></name><name><surname>Hubeck-Graudal</surname><given-names>T</given-names></name><name><surname>J&#x000FC;rgens</surname><given-names>G</given-names></name></person-group><article-title>Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review)</article-title><source>Am J Hypertens</source><volume>25</volume><fpage>1</fpage><lpage>15</lpage><year>2012</year><pub-id pub-id-type="doi">10.1038/ajh.2011.210</pub-id></element-citation></ref>
<ref id="b3-ijmm-37-01-0074"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>FJ</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Macgregor</surname><given-names>GA</given-names></name></person-group><article-title>Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials</article-title><source>BMJ</source><volume>346</volume><fpage>f1325</fpage><year>2013</year><pub-id pub-id-type="doi">10.1136/bmj.f1325</pub-id><pub-id pub-id-type="pmid">23558162</pub-id></element-citation></ref>
<ref id="b4-ijmm-37-01-0074"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>RS</given-names></name><name><surname>Ashton</surname><given-names>KE</given-names></name><name><surname>Moxham</surname><given-names>T</given-names></name><name><surname>Hooper</surname><given-names>L</given-names></name><name><surname>Ebrahim</surname><given-names>S</given-names></name></person-group><article-title>Reduced dietary salt for the prevention of cardiovascular disease: A meta-analysis of randomized controlled trials (Cochrane review)</article-title><source>Am J Hypertens</source><volume>24</volume><fpage>843</fpage><lpage>853</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/ajh.2011.115</pub-id><pub-id pub-id-type="pmid">21731062</pub-id></element-citation></ref>
<ref id="b5-ijmm-37-01-0074"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuhofer</surname><given-names>W</given-names></name><name><surname>Beck</surname><given-names>FX</given-names></name></person-group><article-title>Cell survival in the hostile environment of the renal medulla</article-title><source>Annu Rev Physiol</source><volume>67</volume><fpage>531</fpage><lpage>555</lpage><year>2005</year><pub-id pub-id-type="doi">10.1146/annurev.physiol.67.031103.154456</pub-id><pub-id pub-id-type="pmid">15709969</pub-id></element-citation></ref>
<ref id="b6-ijmm-37-01-0074"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>JH</given-names></name><name><surname>Woo</surname><given-names>SK</given-names></name><name><surname>Han</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Handler</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kwon</surname><given-names>HM</given-names></name></person-group><article-title>Hydration status affects nuclear distribution of transcription factor tonicity responsive enhancer binding protein in rat kidney</article-title><source>J Am Soc Nephrol</source><volume>12</volume><fpage>2221</fpage><lpage>2230</lpage><year>2001</year><pub-id pub-id-type="pmid">11675398</pub-id></element-citation></ref>
<ref id="b7-ijmm-37-01-0074"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x000FC;ltz</surname><given-names>D</given-names></name><name><surname>Chakravarty</surname><given-names>D</given-names></name></person-group><article-title>Hyperosmolality in the form of elevated NaCl but not urea causes DNA damage in murine kidney cells</article-title><source>Proc Natl Acad Sci USA</source><volume>98</volume><fpage>1999</fpage><lpage>2004</lpage><year>2001</year><pub-id pub-id-type="doi">10.1073/pnas.98.4.1999</pub-id><pub-id pub-id-type="pmid">11172065</pub-id><pub-id pub-id-type="pmcid">29371</pub-id></element-citation></ref>
<ref id="b8-ijmm-37-01-0074"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Dmitrieva</surname><given-names>NI</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Levine</surname><given-names>RL</given-names></name><name><surname>Burg</surname><given-names>MB</given-names></name></person-group><article-title>High urea and NaCl carbonylate proteins in renal cells in culture and in vivo, and high urea causes 8-oxoguanine lesions in their DNA</article-title><source>Proc Natl Acad Sci USA</source><volume>101</volume><fpage>9491</fpage><lpage>9496</lpage><year>2004</year><pub-id pub-id-type="doi">10.1073/pnas.0402961101</pub-id><pub-id pub-id-type="pmid">15190183</pub-id><pub-id pub-id-type="pmcid">439004</pub-id></element-citation></ref>
<ref id="b9-ijmm-37-01-0074"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>BC</given-names></name><name><surname>Chevaile</surname><given-names>A</given-names></name><name><surname>H&#x000E9;bert</surname><given-names>MJ</given-names></name><name><surname>Zagajeski</surname><given-names>J</given-names></name><name><surname>Gullans</surname><given-names>SR</given-names></name></person-group><article-title>A combination of NaCl and urea enhances survival of IMCD cells to hyperosmolality</article-title><source>Am J Physiol</source><volume>274</volume><fpage>F1167</fpage><lpage>F1173</lpage><year>1998</year><pub-id pub-id-type="pmid">9841510</pub-id></element-citation></ref>
<ref id="b10-ijmm-37-01-0074"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machnik</surname><given-names>A</given-names></name><name><surname>Neuhofer</surname><given-names>W</given-names></name><name><surname>Jantsch</surname><given-names>J</given-names></name><name><surname>Dahlmann</surname><given-names>A</given-names></name><name><surname>Tammela</surname><given-names>T</given-names></name><name><surname>Machura</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>JK</given-names></name><name><surname>Beck</surname><given-names>FX</given-names></name><name><surname>M&#x000FC;ller</surname><given-names>DN</given-names></name><name><surname>Derer</surname><given-names>W</given-names></name><etal/></person-group><article-title>Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism</article-title><source>Nat Med</source><volume>15</volume><fpage>545</fpage><lpage>552</lpage><year>2009</year><pub-id pub-id-type="doi">10.1038/nm.1960</pub-id><pub-id pub-id-type="pmid">19412173</pub-id></element-citation></ref>
<ref id="b11-ijmm-37-01-0074"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijst</surname><given-names>P</given-names></name><name><surname>Verbrugge</surname><given-names>FH</given-names></name><name><surname>Grieten</surname><given-names>L</given-names></name><name><surname>Dupont</surname><given-names>M</given-names></name><name><surname>Steels</surname><given-names>P</given-names></name><name><surname>Tang</surname><given-names>WH</given-names></name><name><surname>Mullens</surname><given-names>W</given-names></name></person-group><article-title>The pathophysiological role of interstitial sodium in heart failure</article-title><source>J Am Coll Cardiol</source><volume>65</volume><fpage>378</fpage><lpage>388</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.jacc.2014.11.025</pub-id><pub-id pub-id-type="pmid">25634838</pub-id></element-citation></ref>
<ref id="b12-ijmm-37-01-0074"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heer</surname><given-names>M</given-names></name><name><surname>Baisch</surname><given-names>F</given-names></name><name><surname>Kropp</surname><given-names>J</given-names></name><name><surname>Gerzer</surname><given-names>R</given-names></name><name><surname>Drummer</surname><given-names>C</given-names></name></person-group><article-title>High dietary sodium chloride consumption may not induce body fluid retention in humans</article-title><source>Am J Physiol Renal Physiol</source><volume>278</volume><fpage>F585</fpage><lpage>F595</lpage><year>2000</year><pub-id pub-id-type="pmid">10751219</pub-id></element-citation></ref>
<ref id="b13-ijmm-37-01-0074"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkendall</surname><given-names>AM</given-names></name><name><surname>Connor</surname><given-names>WE</given-names></name><name><surname>Abboud</surname><given-names>F</given-names></name><name><surname>Rastogi</surname><given-names>SP</given-names></name><name><surname>Anderson</surname><given-names>TA</given-names></name><name><surname>Fry</surname><given-names>M</given-names></name></person-group><article-title>The effect of dietary sodium chloride on blood pressure, body fluids, electrolytes, renal function, and serum lipids of normotensive man</article-title><source>J Lab Clin Med</source><volume>87</volume><fpage>411</fpage><lpage>434</lpage><year>1976</year><pub-id pub-id-type="pmid">1249473</pub-id></element-citation></ref>
<ref id="b14-ijmm-37-01-0074"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palacios</surname><given-names>C</given-names></name><name><surname>Wigertz</surname><given-names>K</given-names></name><name><surname>Martin</surname><given-names>BR</given-names></name><name><surname>Jackman</surname><given-names>L</given-names></name><name><surname>Pratt</surname><given-names>JH</given-names></name><name><surname>Peacock</surname><given-names>M</given-names></name><name><surname>McCabe</surname><given-names>G</given-names></name><name><surname>Weaver</surname><given-names>CM</given-names></name></person-group><article-title>Sodium retention in black and white female adolescents in response to salt intake</article-title><source>J Clin Endocrinol Metab</source><volume>89</volume><fpage>1858</fpage><lpage>1863</lpage><year>2004</year><pub-id pub-id-type="doi">10.1210/jc.2003-031446</pub-id><pub-id pub-id-type="pmid">15070956</pub-id></element-citation></ref>
<ref id="b15-ijmm-37-01-0074"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Titze</surname><given-names>J</given-names></name><name><surname>Shakibaei</surname><given-names>M</given-names></name><name><surname>Schafflhuber</surname><given-names>M</given-names></name><name><surname>Schulze-Tanzil</surname><given-names>G</given-names></name><name><surname>Porst</surname><given-names>M</given-names></name><name><surname>Schwind</surname><given-names>KH</given-names></name><name><surname>Dietsch</surname><given-names>P</given-names></name><name><surname>Hilgers</surname><given-names>KF</given-names></name></person-group><article-title>Glycosaminoglycan polymerization may enable osmotically inactive Na<sup>+</sup> storage in the skin</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>287</volume><fpage>H203</fpage><lpage>H208</lpage><year>2004</year><pub-id pub-id-type="doi">10.1152/ajpheart.01237.2003</pub-id><pub-id pub-id-type="pmid">14975935</pub-id></element-citation></ref>
<ref id="b16-ijmm-37-01-0074"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>DR</given-names></name><name><surname>Markandu</surname><given-names>ND</given-names></name><name><surname>Sugden</surname><given-names>AL</given-names></name><name><surname>Miller</surname><given-names>MA</given-names></name><name><surname>MacGregor</surname><given-names>GA</given-names></name></person-group><article-title>Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide</article-title><source>Hypertension</source><volume>17</volume><fpage>798</fpage><lpage>803</lpage><year>1991</year><pub-id pub-id-type="doi">10.1161/01.HYP.17.6.798</pub-id><pub-id pub-id-type="pmid">2045142</pub-id></element-citation></ref>
<ref id="b17-ijmm-37-01-0074"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname><given-names>N</given-names></name><name><surname>Kitazato</surname><given-names>KT</given-names></name><name><surname>Tada</surname><given-names>Y</given-names></name><name><surname>Sumiyoshi</surname><given-names>M</given-names></name><name><surname>Shimada</surname><given-names>K</given-names></name><name><surname>Yagi</surname><given-names>K</given-names></name><name><surname>Kanematsu</surname><given-names>Y</given-names></name><name><surname>Satomi</surname><given-names>J</given-names></name><name><surname>Nagahiro</surname><given-names>S</given-names></name></person-group><article-title>Increase in body Na<sup>+</sup>/water ratio is associated with cerebral aneurysm formation in oophorectomized rats</article-title><source>Hypertension</source><volume>60</volume><fpage>1309</fpage><lpage>1315</lpage><year>2012</year><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.112.198762</pub-id><pub-id pub-id-type="pmid">23045463</pub-id></element-citation></ref>
<ref id="b18-ijmm-37-01-0074"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacolley</surname><given-names>P</given-names></name><name><surname>Regnault</surname><given-names>V</given-names></name><name><surname>Nicoletti</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Michel</surname><given-names>JB</given-names></name></person-group><article-title>The vascular smooth muscle cell in arterial pathology: A cell that can take on multiple roles</article-title><source>Cardiovasc Res</source><volume>95</volume><fpage>194</fpage><lpage>204</lpage><year>2012</year><pub-id pub-id-type="doi">10.1093/cvr/cvs135</pub-id><pub-id pub-id-type="pmid">22467316</pub-id></element-citation></ref>
<ref id="b19-ijmm-37-01-0074"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>SY</given-names></name></person-group><article-title>Mechanisms simultaneously regulate smooth muscle proliferation and differentiation</article-title><source>J Biomed Res</source><volume>28</volume><fpage>40</fpage><lpage>46</lpage><year>2014</year><pub-id pub-id-type="doi">10.7555/JBR.28.20130130</pub-id><pub-id pub-id-type="pmid">24474962</pub-id><pub-id pub-id-type="pmcid">3904173</pub-id></element-citation></ref>
<ref id="b20-ijmm-37-01-0074"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Hitomi</surname><given-names>H</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Nakano</surname><given-names>D</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name><name><surname>Masaki</surname><given-names>T</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Iwamoto</surname><given-names>T</given-names></name><name><surname>Kobori</surname><given-names>H</given-names></name><name><surname>Nishiyama</surname><given-names>A</given-names></name></person-group><article-title>High sodium augments angiotensin II-induced vascular smooth muscle cell proliferation through the ERK1/2-dependent pathway</article-title><source>Hypertens Res</source><volume>37</volume><fpage>13</fpage><lpage>18</lpage><year>2014</year><pub-id pub-id-type="doi">10.1038/hr.2013.108</pub-id><pub-id pub-id-type="pmcid">3947370</pub-id></element-citation></ref>
<ref id="b21-ijmm-37-01-0074"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makita</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Hiramori</surname><given-names>K</given-names></name></person-group><article-title>Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells</article-title><source>Life Sci</source><volume>56</volume><fpage>PL383</fpage><lpage>PL388</lpage><year>1995</year><pub-id pub-id-type="doi">10.1016/0024-3205(95)98582-Z</pub-id><pub-id pub-id-type="pmid">7723594</pub-id></element-citation></ref>
<ref id="b22-ijmm-37-01-0074"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komuro</surname><given-names>I</given-names></name><name><surname>Kurihara</surname><given-names>H</given-names></name><name><surname>Sugiyama</surname><given-names>T</given-names></name><name><surname>Yoshizumi</surname><given-names>M</given-names></name><name><surname>Takaku</surname><given-names>F</given-names></name><name><surname>Yazaki</surname><given-names>Y</given-names></name></person-group><article-title>Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells</article-title><source>FEBS Lett</source><volume>238</volume><fpage>249</fpage><lpage>252</lpage><year>1988</year><pub-id pub-id-type="doi">10.1016/0014-5793(88)80489-7</pub-id><pub-id pub-id-type="pmid">3139457</pub-id></element-citation></ref>
<ref id="b23-ijmm-37-01-0074"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ren</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin</article-title><source>Int J Mol Med</source><volume>33</volume><fpage>1341</fpage><lpage>1347</lpage><year>2014</year><pub-id pub-id-type="pmid">24590381</pub-id></element-citation></ref>
<ref id="b24-ijmm-37-01-0074"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wan</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name></person-group><article-title>17&#x003B2;-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor &#x003B1;-dependent pathway</article-title><source>Int J Mol Med</source><volume>33</volume><fpage>550</fpage><lpage>558</lpage><year>2014</year><pub-id pub-id-type="pmid">24398697</pub-id></element-citation></ref>
<ref id="b25-ijmm-37-01-0074"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weissberg</surname><given-names>PL</given-names></name><name><surname>Cary</surname><given-names>NR</given-names></name><name><surname>Shanahan</surname><given-names>CM</given-names></name></person-group><article-title>Gene expression and vascular smooth muscle cell phenotype</article-title><source>Blood Press Suppl</source><volume>2</volume><fpage>68</fpage><lpage>73</lpage><year>1995</year><pub-id pub-id-type="pmid">7582079</pub-id></element-citation></ref>
<ref id="b26-ijmm-37-01-0074"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salic</surname><given-names>A</given-names></name><name><surname>Mitchison</surname><given-names>TJ</given-names></name></person-group><article-title>A chemical method for fast and sensitive detection of DNA synthesis in vivo</article-title><source>Proc Natl Acad Sci USA</source><volume>105</volume><fpage>2415</fpage><lpage>2420</lpage><year>2008</year><pub-id pub-id-type="doi">10.1073/pnas.0712168105</pub-id><pub-id pub-id-type="pmid">18272492</pub-id><pub-id pub-id-type="pmcid">2268151</pub-id></element-citation></ref>
<ref id="b27-ijmm-37-01-0074"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzi&#x00144;ska-Ustymowicz</surname><given-names>K</given-names></name><name><surname>Pryczynicz</surname><given-names>A</given-names></name><name><surname>Kemona</surname><given-names>A</given-names></name><name><surname>Czyzewska</surname><given-names>J</given-names></name></person-group><article-title>Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer</article-title><source>Anticancer Res</source><volume>29</volume><fpage>3049</fpage><lpage>3052</lpage><year>2009</year></element-citation></ref>
<ref id="b28-ijmm-37-01-0074"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Bu</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>AD</given-names></name><name><surname>Holmberg</surname><given-names>L</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name></person-group><article-title>Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk/MAP kinase pathway mediated by cAMP/PKA signaling</article-title><source>Cell Death Dis</source><volume>5</volume><fpage>e1251</fpage><year>2014</year><pub-id pub-id-type="doi">10.1038/cddis.2014.229</pub-id><pub-id pub-id-type="pmid">24853429</pub-id><pub-id pub-id-type="pmcid">4047873</pub-id></element-citation></ref>
<ref id="b29-ijmm-37-01-0074"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boutros</surname><given-names>T</given-names></name><name><surname>Chevet</surname><given-names>E</given-names></name><name><surname>Metrakos</surname><given-names>P</given-names></name></person-group><article-title>Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: Roles in cell growth, death, and cancer</article-title><source>Pharmacol Rev</source><volume>60</volume><fpage>261</fpage><lpage>310</lpage><year>2008</year><pub-id pub-id-type="doi">10.1124/pr.107.00106</pub-id><pub-id pub-id-type="pmid">18922965</pub-id></element-citation></ref>
<ref id="b30-ijmm-37-01-0074"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cargnello</surname><given-names>M</given-names></name><name><surname>Roux</surname><given-names>PP</given-names></name></person-group><article-title>Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases</article-title><source>Microbiol Mol Biol Rev</source><volume>75</volume><fpage>50</fpage><lpage>83</lpage><year>2011</year><pub-id pub-id-type="doi">10.1128/MMBR.00031-10</pub-id><pub-id pub-id-type="pmid">21372320</pub-id><pub-id pub-id-type="pmcid">3063353</pub-id></element-citation></ref>
<ref id="b31-ijmm-37-01-0074"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powles</surname><given-names>J</given-names></name><name><surname>Fahimi</surname><given-names>S</given-names></name><name><surname>Micha</surname><given-names>R</given-names></name><name><surname>Khatibzadeh</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>P</given-names></name><name><surname>Ezzati</surname><given-names>M</given-names></name><name><surname>Engell</surname><given-names>RE</given-names></name><name><surname>Lim</surname><given-names>SS</given-names></name><name><surname>Danaei</surname><given-names>G</given-names></name><name><surname>Mozaffarian</surname><given-names>D</given-names></name><etal/><collab>Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE)</collab></person-group><article-title>Global, regional and national sodium intakes in 1990 and 2010: A systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide</article-title><source>BMJ Open</source><volume>3</volume><fpage>e003733</fpage><year>2013</year><pub-id pub-id-type="doi">10.1136/bmjopen-2013-003733</pub-id><pub-id pub-id-type="pmid">24366578</pub-id><pub-id pub-id-type="pmcid">3884590</pub-id></element-citation></ref>
<ref id="b32-ijmm-37-01-0074"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaustein</surname><given-names>MP</given-names></name><name><surname>Leenen</surname><given-names>FHH</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Golovina</surname><given-names>VA</given-names></name><name><surname>Hamlyn</surname><given-names>JM</given-names></name><name><surname>Pallone</surname><given-names>TL</given-names></name><name><surname>Van Huysse</surname><given-names>JW</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wier</surname><given-names>WG</given-names></name></person-group><article-title>How NaCl raises blood pressure: A new paradigm for the pathogenesis of salt-dependent hypertension</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>302</volume><fpage>H1031</fpage><lpage>H1049</lpage><year>2012</year><pub-id pub-id-type="doi">10.1152/ajpheart.00899.2011</pub-id><pub-id pub-id-type="pmcid">3311458</pub-id></element-citation></ref>
<ref id="b33-ijmm-37-01-0074"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duzgun</surname><given-names>SA</given-names></name><name><surname>Rasque</surname><given-names>H</given-names></name><name><surname>Kito</surname><given-names>H</given-names></name><name><surname>Azuma</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Basson</surname><given-names>MD</given-names></name><name><surname>Gahtan</surname><given-names>V</given-names></name><name><surname>Dudrick</surname><given-names>SJ</given-names></name><name><surname>Sumpio</surname><given-names>BE</given-names></name></person-group><article-title>Mitogen-activated protein phosphorylation in endothelial cells exposed to hyperosmolar conditions</article-title><source>J Cell Biochem</source><volume>76</volume><fpage>567</fpage><lpage>571</lpage><year>2000</year><pub-id pub-id-type="doi">10.1002/(SICI)1097-4644(20000315)76:4&lt;567::AID-JCB5&gt;3.0.CO;2-W</pub-id><pub-id pub-id-type="pmid">10653976</pub-id></element-citation></ref>
<ref id="b34-ijmm-37-01-0074"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinewietfeld</surname><given-names>M</given-names></name><name><surname>Manzel</surname><given-names>A</given-names></name><name><surname>Titze</surname><given-names>J</given-names></name><name><surname>Kvakan</surname><given-names>H</given-names></name><name><surname>Yosef</surname><given-names>N</given-names></name><name><surname>Linker</surname><given-names>RA</given-names></name><name><surname>Muller</surname><given-names>DN</given-names></name><name><surname>Hafler</surname><given-names>DA</given-names></name></person-group><article-title>Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells</article-title><source>Nature</source><volume>496</volume><fpage>518</fpage><lpage>522</lpage><year>2013</year><pub-id pub-id-type="doi">10.1038/nature11868</pub-id><pub-id pub-id-type="pmid">23467095</pub-id><pub-id pub-id-type="pmcid">3746493</pub-id></element-citation></ref>
<ref id="b35-ijmm-37-01-0074"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Ferraris</surname><given-names>JD</given-names></name><name><surname>Dmitrieva</surname><given-names>NI</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Burg</surname><given-names>MB</given-names></name></person-group><article-title>MKP-1 inhibits high NaCl-induced activation of p38 but does not inhibit the activation of TonEBP/OREBP: Opposite roles of p38alpha and p38delta</article-title><source>Proc Natl Acad Sci USA</source><volume>105</volume><fpage>5620</fpage><lpage>5625</lpage><year>2008</year><pub-id pub-id-type="doi">10.1073/pnas.0801453105</pub-id><pub-id pub-id-type="pmid">18367666</pub-id><pub-id pub-id-type="pmcid">2291081</pub-id></element-citation></ref>
<ref id="b36-ijmm-37-01-0074"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaeschke</surname><given-names>A</given-names></name><name><surname>Karasarides</surname><given-names>M</given-names></name><name><surname>Ventura</surname><given-names>JJ</given-names></name><name><surname>Ehrhardt</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name><name><surname>Shokat</surname><given-names>KM</given-names></name><name><surname>Davis</surname><given-names>RJ</given-names></name></person-group><article-title>JNK2 is a positive regulator of the cJun transcription factor</article-title><source>Mol Cell</source><volume>23</volume><fpage>899</fpage><lpage>911</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.molcel.2006.07.028</pub-id><pub-id pub-id-type="pmid">16973441</pub-id></element-citation></ref>
<ref id="b37-ijmm-37-01-0074"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meloche</surname><given-names>S</given-names></name><name><surname>Pouyss&#x000E9;gur</surname><given-names>J</given-names></name></person-group><article-title>The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition</article-title><source>Oncogene</source><volume>26</volume><fpage>3227</fpage><lpage>3239</lpage><year>2007</year><pub-id pub-id-type="doi">10.1038/sj.onc.1210414</pub-id><pub-id pub-id-type="pmid">17496918</pub-id></element-citation></ref>
<ref id="b38-ijmm-37-01-0074"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuadrado</surname><given-names>A</given-names></name><name><surname>Nebreda</surname><given-names>AR</given-names></name></person-group><article-title>Mechanisms and functions of p38 MAPK signalling</article-title><source>Biochem J</source><volume>429</volume><fpage>403</fpage><lpage>417</lpage><year>2010</year><pub-id pub-id-type="doi">10.1042/BJ20100323</pub-id><pub-id pub-id-type="pmid">20626350</pub-id></element-citation></ref>
<ref id="b39-ijmm-37-01-0074"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikhailov</surname><given-names>A</given-names></name><name><surname>Shinohara</surname><given-names>M</given-names></name><name><surname>Rieder</surname><given-names>CL</given-names></name></person-group><article-title>The p38-mediated stress-activated checkpoint. A rapid response system for delaying progression through antephase and entry into mitosis</article-title><source>Cell Cycle</source><volume>4</volume><fpage>57</fpage><lpage>62</lpage><year>2005</year><pub-id pub-id-type="doi">10.4161/cc.4.1.1357</pub-id></element-citation></ref>
<ref id="b40-ijmm-37-01-0074"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perdiguero</surname><given-names>E</given-names></name><name><surname>Ruiz-Bonilla</surname><given-names>V</given-names></name><name><surname>Serrano</surname><given-names>AL</given-names></name><name><surname>Mu&#x000F1;oz-C&#x000E1;noves</surname><given-names>P</given-names></name></person-group><article-title>Genetic deficiency of p38alpha reveals its critical role in myoblast cell cycle exit: The p38alpha-JNK connection</article-title><source>Cell Cycle</source><volume>6</volume><fpage>1298</fpage><lpage>1303</lpage><year>2007</year><pub-id pub-id-type="doi">10.4161/cc.6.11.4315</pub-id><pub-id pub-id-type="pmid">17534150</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-ijmm-37-01-0074" position="float">
<label>Figure 1</label>
<caption>
<p>Effects of additional NaCl, choline chloride and sorbital on the proliferation of vascular smooth muscle cells (VSMCs). (A&#x02013;C) MTT assay for the proliferation of VSMCs following treatment with additional (A) NaCl, (B) choline chloride and (C) sorbital for 24 h. (D) MTT assay for the proliferation of VSMCs following treatment with or without additional NaCl (30 mM) for 12, 24 and 48 h, respectively. Data are expressed as the means &#x000B1; SD from at least 3 independent experiments. <sup>&#x0002A;</sup>P&lt;0.05 vs. control (untreated cells) at the same time point.</p></caption>
<graphic xlink:href="IJMM-37-01-0074-g00.tif"/></fig>
<fig id="f2-ijmm-37-01-0074" position="float">
<label>Figure 2</label>
<caption>
<p>Effects of high sodium level on DNA synthesis. (A) 5-Ethynyl-2&#x02032;-deoxyuridine (EdU) incorporation assay of vascular smooth muscle cells (VSMCs) following treatment with additional NaCl (30 mM) or not for 24 h. Red and blue fluorescence represent EdU-positive nuclei and general nuclei, respectively (magnification, &#x000D7;400). (B) Quantification of the percentage of EdU-positive nuclei to total nuclei. Data are expressed as the means &#x000B1; SD from 3 independent experiments. <sup>&#x0002A;</sup>P&lt;0.05 vs. control (untreated cells).</p></caption>
<graphic xlink:href="IJMM-37-01-0074-g01.tif"/></fig>
<fig id="f3-ijmm-37-01-0074" position="float">
<label>Figure 3</label>
<caption>
<p>Expression of proliferating cell nuclear antigen (PCNA) in vascular smooth muscle cells (VSMCs). (A) PCNA expression at the mRNA level in VSMCs treated with or without additional Na<sup>+</sup> (30 mM) for the indicated periods of time. Beta-glucuronidase (GUSB) was used as a loading control. (B) Western blot analysis of PCNA in cells following treatment with or without additional Na<sup>+</sup> for the indicated periods of time. &#x003B2;-actin was used as a loading control. Average quantification obtained by densitometric analysis of the results of western blot analysis. Data are presented as the mean &#x000B1; SD from 3 independent experiments. <sup>&#x0002A;</sup>p&lt;0.05 vs. control (untreated cells) at the same time point.</p></caption>
<graphic xlink:href="IJMM-37-01-0074-g02.tif"/></fig>
<fig id="f4-ijmm-37-01-0074" position="float">
<label>Figure 4</label>
<caption>
<p>Expression of phosphorylated c-Jun amino N-terminal kinases (p-JNK), phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2) and phosphorylated p-p38 mitogen-activated protein kinase (p-p38 MAPK) in vascular smooth muscle cells (VSMCs). (A, C and E) Representive western blots of (A) p-JNK, (C) p-ERK1/2 and (E) p-p38 MAPK in VSMCs treated with or without additional Na<sup>+</sup> for the indicated periods of time. &#x003B2;-actin was used as a loading control. (B, D and F) Average quantification obtained by densitometric analysis of the results of western blot analysis. Data are presented as the means &#x000B1; SD from at least 3 independent experiments. <sup>&#x0002A;</sup>P&lt;0.05 vs. control (untreated cells).</p></caption>
<graphic xlink:href="IJMM-37-01-0074-g03.tif"/></fig>
<fig id="f5-ijmm-37-01-0074" position="float">
<label>Figure 5</label>
<caption>
<p>Roles of phosphorylated c-Jun amino N-terminal kinases (p-JNK) and phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2) in the proliferation of vascular smooth muscle cells (VSMCs) induced by high sodium. (A and B) Western blot analysis of proliferating cell nuclear antigen (PCNA) in VSMCs treated with (A) SP600125 (a JNK inhibitor), (B) PD980591 (an ERK1/2 inhibitor) for 30 min prior to exposure to additional Na<sup>+</sup> (30 mM) for a further 15 h. (C and D) Western blot analysis of p-JNK and p-ERK in VSMCs treated with (C) SP600125 and (D) PD980591 for 30 min prior to exposure to additional Na<sup>+</sup> (30 mM) for a further 30 min. &#x003B2;-actin was used as a loading control. Average quantification obtained by densitometric analysis of the results of western blot analysis. Data are presented as the means &#x000B1; SD from 3 independent experiments. <sup>&#x0002A;</sup>P&lt;0.05 vs. control (untreated cells); <sup>#</sup>P&lt;0.05 vs. cells treated with NaCl alone.</p></caption>
<graphic xlink:href="IJMM-37-01-0074-g04.tif"/></fig>
<fig id="f6-ijmm-37-01-0074" position="float">
<label>Figure 6</label>
<caption>
<p>Role of phosphorylated p38 mitogen-activated protein kinase (p-p38 MAPK) in the proliferation of vascular smooth muscle cells (VSMCs) induced by high sodium. (A and B) Western blot analysis of proliferating cell nuclear antigen (PCNA) in VSMCs treated with (A) SB203580 (a p38 MAPK inhibitor) and (B) anisomycin (a p38 MAPK activator) for 30 min prior to exposure to additional Na<sup>+</sup> (30 mM) for a further 15 h. Average quantification obtained by densitometric analysis of the results of western blot analysis. Data are presented as the means &#x000B1; SD from 3 independent experiments. <sup>&#x0002A;</sup>P&lt;0.05 vs. control (untreated cells); <sup>#</sup>P&lt;0.05 vs. cells treated with NaCl alone. (C and D) Representative western blots of p-p38 MAPK in VSMCs treated with (C) p38 SB203580 and (D) anisomycin for 30 min prior to exposure to additional Na<sup>+</sup> (30 mM) for a further 30 min. &#x003B2;-actin was used as a loading control.</p></caption>
<graphic xlink:href="IJMM-37-01-0074-g05.tif"/></fig>
<fig id="f7-ijmm-37-01-0074" position="float">
<label>Figure 7</label>
<caption>
<p>Schematic diagram of the mechanisms through which high sodium levels increase the proliferation of vascular smooth muscle cells (VSMCs).</p></caption>
<graphic xlink:href="IJMM-37-01-0074-g06.tif"/></fig></floats-group></article>
